Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2000-11-24
2010-06-29
Bausch, Sarae (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C435S091200
Reexamination Certificate
active
07745112
ABSTRACT:
There are disclosed genetic screens for predicting the likely extent of tobacco consumption in human subjects based on screening for the presence or absence of genetic variants shown to be associated with tobacco consumption in smokers.
REFERENCES:
patent: 5500343 (1996-03-01), Blum et al.
patent: 5783680 (1998-07-01), Brunner et al.
patent: 2001/0051344 (2001-12-01), Shalon et al.
patent: WO 98/48785 (1998-11-01), None
patent: WO 99/27919 (1999-06-01), None
patent: WO 01/38567 (2001-05-01), None
Rossing et al. “Genetic Influences on Smoking: Candidate Genes” Environmental Health Perspectives, May 1998, vol. 106, pp. 231-238.
Lucentini, J. “Gene Association Studies Typically Wrong” The Scientist, 2004, vol. 20, p. 20.
Kroese et al. “Genetic tests and their evaluation: Can we answer the key questions?”Genetics in Medicine, Nov./Dec. 2004, vol. 6, No. 6, pp. 475-480.
Kobayashi et al. “Human dopamine hydroxylase gene: two mRNA types having difference 3'-terminal regions are produced through alternative polyadneylation”, Nucleic Acid Research, 1989, vol. 17, pp. 1089-1102.
Johnstone et al. “Genetic Variation in Dopaminergic Pathways and Short term effectiveness of the Nicotine Patch”, Pharmacogenomics, 2004, 14:83-90.
Johnstone et al. “Polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers: seekign confirmation of the association in a follow-up study”, Pharmacogenomics, 2002, 12:585-587.
GenBank accession No. X13264.
GenBank Accession No. X13260.
Ionnidis Plost Med, 2005, 2(8):e124.
Hattersley et al. Lancet, 2005, vol. 366, pp. 1315-1323.
Kim et al. Am. J. of Med. Genetics, 2002, 108:140-147.
Hegele, Arterioscler. Thromb. Vasc. Biol. 2002, 22:1058-1061.
Bell et al., The New Genetics in Clinical Practice, British Journal of Medicine, 316(Feb. 14): 618-20, 1998.
Benowitz et al., Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addition, New England Journal of Medicine, 319: 1318-30, 1988.
Blum et al., Dopamine D2 Receptor Gene Variants: Association and Linkage Studies in Impulsive-addictive-compulsive Behaviour, Pharmacogenetics, 5(3): 121-41, 1995.
Boustead et al., CYP2D6 Genotype and Smoking Behaviour in Cigarette Smokers, Pharmacogenetics, 7(5): 411-4, 1997.
Bunce et al., Molecular HLA Typing the Brave New World, Transplantation, 64(11): 1505-13, 1997.
Bunce et al., Phototyping: Comprehensive DNA Typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5, DQB1 by PCR with 144 Primer Mixes Utilizing Sequence-specific Primers (PCR-SSP), Tissue Antigens, 46(5): 355-67, 1995.
Callum et al., The UK Smoking Epidemic, London, Health Education Authority, 1998.
Caporaso et al., The Genetics of Smoking: The Dopamine Receptor Transporter (DAT) Polymorphisms in a Smoking Cessation Study (abstract), Proceedings of the American Association for Cancer Research, 38: 168-9, 1997.
Cholerton et al., Poor Metabolisers of Nicotine and CYP2D6 Polymorphism, Lancet, 343(8888): 62-3, 1994.
Clarke et al., Tobacco Smoking, Genes and Dopamine, Lancet, 352(9122): 84-5, 1998.
Comings et al., Studies of the Potential Role of the Dopamine D1 Receptor Gene in Addictive Behaviours, Molecular Psychiatry, 2(1): 44-56, 1997.
Comings et al., The Dopamine D2 Receptor (DRD2) Gene: A Genetic Risk Factor in Smoking, Pharmacogenetics, 6(1): 73-9, 1996.
Cubells et al., Dopamine Beta-hydroxylase: Two Polymorphisms in Linkage Disequilibrium at the Structural Gene DBH Associate with Biochemical Phenotypic Variation, Human Genetics, 102: 533-540, 1998.
Faraj et al., Platelet Monoamine Oxidase Activity in Alcoholics, Alcoholics with Drug Dependence, and Cocaine Addicts, Alcohol Clinical and Experimental Research, 18(5): 1114-20, 1994.
Fowler et al., Neuropharmacological Actions of Cigarette Smoke: Brain Monoamine Oxidase B(MAO B) Inhibition, Journal of Addictive Diseases, 17(1): 23-34, 1998.
Gabel et al., Homovanillic Acid and Dopamine-beta-hydroxylase in Male Youth; Relationships with Paternal Substance Abuse and Antisocial Behaviour, American Journal of Drug and Alcohol Abuse, 21(3): 363-78, 1995.
Garcia-Closas et al., Association between CYP1A1 Polymorphism and Smoking in a Control Population: Implications for the Study of Genetic Factors on Cancer Risk, Proceedings for the American Association for Cancer Research, 38(Mar.): 211, 1997.
Heath et al., Personality and the Inheritance of Smoking Behaviour: A Genetic Perspective, Behavioral Genetics, 25(2): 103-17, 1995.
Heath et al., Genetic Contribution to Risk of Smoking Initiation; Comparisons Across Birth Cohorts and Across Cultures, Journal of Substance Abuse, 5(3): 221-46, 1993.
Hurt et al., A Comparison of Sustained-release Bupropion and Placebo for Smoking Cessation, New England Journal of Medicine, 337(17): 1195-202, 1997.
Imperial Cancer Research Fund, General Practice Research Group, Effectiveness of a Nicotine Patch in Helping People Stop Smoking: Results of a Randomised Trail in General Practice, British Medical Journal, 306(6888): 1304-8, 1993.
Imperial Cancer Research Fund, Oxcheck Study Group, Effectiveness of Health Checks Conducted by Nurses in Primary Care: Final Results of the Oxcheck Study, British Medical Journal, 310(6987): 1099-104, 1995.
Jorenby et al., A Controlled Trial of Sustained-release Bupropion, a Nicotine Patch, or Both for Smoking Cessation, New England Journal of Medicine, 340(9): 685-91, 1999.
Lerman et al., Lack of Association of Tyrosine Hydroxylase Genetic Polymorphism with Cigarette Smoking, Pharmacogenetics, 7(6): 521-4, 1997.
Lerman et al., Evidence Suggesting the Role of Specific Genetic Factors in Cigarette Smoking, Health Psychology, 18(1): 14-20, 1999.
MacKay et al., Tobacco and the Developing World, British Medical Bulletin, 52(1): 206-21, 1996.
McKinney et al., Association Between Polymorphisms in Dopamine Metabolic Enzymes and Tobacco Consumption in Smokers, Pharmacogenetics, 10(6): 483-91, 2000.
Noble et al., D2 Dopamine Receptor Gene and Cigarette Smoking: A Reward Gene?, Medical Hypotheses, 42(4): 257-60, 1994.
Pastinen et al., Minisequencing: a specific tool for DNA analysis and diagnostics on oligonucleotide arrays, Genome Research, 7: 606-14, 1997.
Pianezza et al., Nicotine Metabolism Defect Reduces Smoking, Nature, 393: 750, 1998.
Roskey et al., DNA sequencing by delayed extraction-matrix-assisted laser desorption/ionization time of flight mass spectrometry, Proceedings of the National Academy of Science USA, 93: 4724-9, 1996.
Rossing et al., Genetic Influences on Smoking: Candidate Genes, Environmental Health Perspectives, 106(5): 231-8, 1998.
Sabol et al., A Genetic Association for Cigarette Smoking Behaviour, Health Psychology, 18(1): 7-13, 1999.
Schafer et al., DNA variation and the future of human genetics, Nature Biotechnology, 16: 33-9, 1998.
Schneider et al., Efficacy of a Nicotine Nasal Spray in Smoking Cessation: A Placebo-controlled Double-blind Trial, Addiction, 90(12): 1671-82, 1995.
Sellers et al., Pharmacogenetics and Ethnoracial Differences in Smoking, Journal of the American Medical Association, 280(2): 179-80, 1998.
Shields et al., Dopamine D4 Receptors and the Risk of Cigarette Smoking in African-Americans and Caucasians, Cancer Epidemiology, Biomarkers, and Prevention, 7(6): 453-8, 1998.
Shumaker et al., Mutation detection by solid phase primer extension, Human Mutations, 7: 346-54, 1996.
True et al., Genetic and Environmental Contributions to Smoking, Addiction, 92(10): 1277-87, 1997.
Underhill et al., A pre-Columbian Y chromosome-specific transition and its implications for human evolutionary history, Proceedings of the National Academy of Science USA, 93: 196-200, 1996.
Vandenberg et al., High-activity Catechol-O-methyltransferase Allele is More Prevalent in Polysubstance Abusers, American Journal of Medical Genetics, 74(4): 439-42, 1997.
Van Der Sande et al., Nationwide Prevalence Study of Hypertension and Related Non-communicable Diseases in The Gambia, Tropical Medicine and International Health, 2(11): 1039-48, 1997.
Wicklegreen, I. Teaching the Brain to Take Drugs, Science, 280(Ju
Marshall Sara
McKinney Eoin
Murphy Michael
Walton Robert
Welsh Kenneth
Bausch Sarae
g-Nostics Limited
Wolf Greenfield & Sacks P.C.
LandOfFree
Genetic indicators of tobacco consumption does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genetic indicators of tobacco consumption, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetic indicators of tobacco consumption will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4163829